Literature DB >> 12048126

Spontaneous atherosclerosis in the proximal aorta of LPA transgenic mice on a normal diet.

Kåre Berg1, Aud Svindland, Adrian J Smith, Richard M Lawn, Srdjan Djurovic, Annette Aleström, Peter Aleström, Knut Eliassen.   

Abstract

Serum levels of Lp(a) lipoprotein are under genetic control and a high level is a risk factor for atherosclerotic disease. We have examined the aorta of LPA transgenic mice and their non-transgenic litter mates who had all been given a regular, not lipid fortified diet. When sacrificed, the animals had an average age of 66 weeks. Lipid lesions were observed in the aorta of 13 out of 18 LPA transgenic mice and in five out of 21 non-transgenic animals. The difference is statistically significant. We conclude that LPA transgenic mice develop lipid lesions in aorta more frequently than non-transgenic animals, even on a diet with a low fat content. LPA transgenic mice on a normal diet could be a useful animal model for the study of spontaneous human atherosclerosis, its treatment and prevention.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048126     DOI: 10.1016/s0021-9150(01)00772-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

Review 1.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

2.  Rhesus monkey (Macaca mulatta) lipoprotein(a) and apolipoprotein(a): high frequency of small size apolipoprotein(a) isoforms.

Authors:  Byambaa Enkhmaa; Adnan Abbuthalha; Erdembileg Anuurad; Wei Zhang; Alice F Tarantal; Lars Berglund
Journal:  J Med Primatol       Date:  2015-02-12       Impact factor: 0.667

3.  Lipoprotein(a) accelerates atherosclerosis in uremic mice.

Authors:  Tanja X Pedersen; Sally P McCormick; Sotirios Tsimikas; Susanne Bro; Lars B Nielsen
Journal:  J Lipid Res       Date:  2010-06-28       Impact factor: 5.922

Review 4.  Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications.

Authors:  Angelo M Scanu
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

5.  Lipoprotein(a): biology and clinical importance.

Authors:  Sally P A McCormick
Journal:  Clin Biochem Rev       Date:  2004-02

6.  Proteomic analysis of aortae from human lipoprotein(a) transgenic mice shows an early metabolic response independent of atherosclerosis.

Authors:  Euan J Rodger; Rachel J Suetani; Gregory T Jones; Torsten Kleffmann; Alan Carne; Michael Legge; Sally P A McCormick
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

7.  Activity of peroxisomal enzymes, and levels of polyamines in LPA-transgenic mice on two different diets.

Authors:  Knut A Eliassen; Bjørn P Brodal; Aud Svindland; Harald Osmundsen; Helle Rønning; Srdjan Djurovic; Kåre Berg
Journal:  Lipids Health Dis       Date:  2005-10-04       Impact factor: 3.876

8.  Production of Cloned Miniature Pigs Expressing High Levels of Human Apolipoprotein(a) in Plasma.

Authors:  Masayuki Ozawa; Takehiro Himaki; Shoji Ookutsu; Yamato Mizobe; Junki Ogawa; Kazuchika Miyoshi; Akira Yabuki; Jianglin Fan; Mitsutoshi Yoshida
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

9.  Human apoB contributes to increased serum total apo(a) level in LPA transgenic mice.

Authors:  Päivi A Teivainen; Knut A Eliassen; Edward M Rubin; Srdjan Djurovic; Kåre Berg
Journal:  Lipids Health Dis       Date:  2004-05-11       Impact factor: 3.876

10.  Proteomic Analysis of Liver from Human Lipoprotein(a) Transgenic Mice Shows an Oxidative Stress and Lipid Export Response.

Authors:  Euan J Rodger; Carolyn M Porteous; Gregory T Jones; Michael Legge; Torsten Kleffmann; Sally P A McCormick
Journal:  Biomed Res Int       Date:  2018-11-25       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.